The Strain

The AKK PROBIO® Strain

A proprietary gut-derived Akkermansia muciniphila strain, CGMCC No.20955, selected from 200+ candidates and developed for branded B2B ingredient applications.

CGMCC No.20955strain designation
200+Akkermansia candidates screened
Live + Pasteurizedtwo forms, one strain
18invention patents

Origin and selection

Gut-derived, then screened for industrial relevance

AKK PROBIO® was isolated from the gut microbiota of a healthy Chinese swimming champion, the natural habitat of Akkermansia muciniphila. Thankcome selected the strain from 200+ candidates based on survival in GI conditions, mucin-degradation capacity, short-chain-fatty-acid production, safety, and scalability.

Strain logic

Human intestinal origin

A gut-derived strain selected for biological relevance, controlled screening criteria, and manufacturable live and pasteurized forms.

AKK PROBIO mechanism diagram showing gut barrier and metabolic signaling pathways

Mechanism context

Mechanism research across barrier, metabolic, and immune pathways

AKK PROBIO® research explores intestinal barrier function, SCFA signaling, GLP-1/2 pathways, Amuc_1100, and immune-regulation mechanisms relevant to technical ingredient evaluation.

01

Human gut origin

Isolated from the natural habitat of Akkermansia muciniphila.

02

200+ screening

Evaluated for safety, function, stability, and industrial feasibility.

03

Two-form platform

Live probiotic and pasteurized postbiotic options for different applications.

04

IP-backed ingredient

18 granted domestic and international invention patents.

Need samples, specs, or regulatory documents?

Share your technical, regulatory, or commercial needs and our team will connect you with the right materials.

Request a Sample